Research

November 26, 2024

Novel genetics approach enhances discovery of disease risk genes

VUMC researchers applied the new approach to large GWAS datasets for breast, prostate and lung cancers, and three brain disorders.

By Leigh MacMillan
(iStock image)
November 25, 2024

Potential treatment eyed for abnormal blood cell disorder

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminate potential,” or CHIP. 

By Bill Snyder
November 21, 2024

Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees

By Marissa Shapiro
November 19, 2024

Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

By Bill Snyder
November 15, 2024

New radiation therapy approach for treating lung cancers

VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan.

By Mahima Sharma
November 15, 2024

Zinc deficiency promotes Acinetobacter lung infection: study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

By Leigh MacMillan
November 14, 2024

VUMC receives $3.3 million ARPA-H award to develop at-home therapy for preterm labor

This project will be the first to apply drug conjugates in the field of obstetrics.
By Danny Bonvissuto
November 14, 2024

Studies to explore molecular drivers of pulmonary diseases

Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.
By Nancy Humphrey
November 13, 2024

New Video: Only half of young cancer patients report discussing fertility preservation

Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion.
By Tom Wilemon
November 12, 2024

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.
By Leigh MacMillan
November 8, 2024

In-clinic reconstruction of skin cancer defects costs less than OR procedures

Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.
By Kanchana Devanathan
November 8, 2024

People with schizophrenia show distinct brain activity when faced with conflicting information

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.
By Joseph Caputo
November 3, 2024

Greenlight study demonstrates effective early intervention in preventing childhood obesity

Researchers examined if childhood obesity could be prevented by leveraging a combination of health behavior counseling offered by pediatric primary care clinicians and modern digital health literacy tools.
By Christina Echegaray